329
Participants
Start Date
December 31, 2009
Primary Completion Date
November 30, 2011
Study Completion Date
January 31, 2012
MEDI528 30 mg
MEDI-528 at a dose of 30 mg administered as a subcutaneous injection every 2 weeks for 24 weeks
MEDI528 100 mg
MEDI-528 at a dose of 100 mg administered as a subcutaneous injection every 2 weeks for 24 weeks
MEDI528 300 mg
MEDI-528 at a dose of 300 mg administered as a subcutaneous injection every 2 weeks for 24 weeks
Placebo
Placebo administered as a subcutaneous injection every 2 weeks for 24 weeks
Research Site, Quezon City
Research Site, Ciudad Autonoma Bs As
Research Site, Buenos Aire
Research Site, Ciudad de Buenos Aire
Research Site, Rosario
Research Site, Iloilo City
Research Site, Silver Spring
Research Site, Baltimore
Research Site, Greenville
Research Site, Kissimmee
Research Site, Pell City
Research Site, Louisville
Research Site, Sylvania
Research Site, Minneapolis
Research Site, Normal
Research Site, Overland Park
Research Site, Omaha
Research Site, San Antonio
Research Site, El Paso
Research Site, Centennial
Research Site, Thornton
Research Site, Colarado Springs
Research Site, Los Angeles
Research Site, San Diego
Research Site, Sacramento
Research Site, Medford
Research Site, Waterbury
Research Site, North Dartmouth
Research Site, Mount Laurel
Research Site, Lincoln
Research Site, San Miguel de Tucumán
Research Site, Buenos Aires
Research Site, Porto Alegre
Research Site, Porto Alegre
Research Site, Florianópolis
Research Site, Santo André
Research Site, São Paulo
Research Site, Calgary
Research Site, Edmonton
Research Site, Vancouver
Research Site, Mississauga
Research Site, Ottawa
Research Site, Montreal
Research Site, Québec
Research Site, Québec
Research Site, Bogota DC
Research Site, Bogota
Research Site, Bogotá D.C.
Research Site, San Francisco de Dos Ríos
Research Site, Panama City
Research Site, Lima
Research Site, Lipa City
Research Site, Kaohsiung City
Research Site, Taoyuan District
Research Site, Lima
Research Site, Lima
Research Site, Jesus Maria
Lead Sponsor
MedImmune LLC
INDUSTRY